CLINICAL ROLE -
Lifestyle Changes Could Mitigate Thousands of Cancers Each Week
Smoking and obesity account for a significant number of cancers worldwide.
Read More
Lymph Node Surgery Unnecessary for Patients with Certain Breast Cancer Subtypes
Triple-negative and HER2-positive breast cancers may be unlikely to develop lymph node metastases.
CAR T-Cell Therapies, Biosimilars May Accelerate Push Towards Alternative Payment Models
Innovative specialty drugs could result in more payers adopting value-based contracting.
Emergency Department Could Fill Gaps in HIV Diagnoses
Emergency departments are a safety net for low-income patients, many of whom may be at risk of HIV.
Newer Specialty Drugs Have Led to a Need for Revised Coverage Strategies
Newer Specialty Drugs Require Payers to Revise Coverage Strategies
CAR T-cell therapies and biosimilars require new strategies compared with traditional drugs.
Obesity Increases DNA Damage Among Patients with BRCA Mutations
Overweight patients with BRCA mutations may be more likely to develop breast cancer.
Do DIR Fees Stand a Chance in 2018?
The future of direct and indirect remuneration fees is in question, according to industry experts.
Telomere Targeting Effective Against Drug-Resistant Melanoma
Immunotherapies for melanoma may be rendered ineffective by drug-resistant cells.
Menopause May Worsen Fatigue, Muscle Aches Among HIV-Positive Women
Health care providers should be aware of how HIV symptoms may affect menopausal women.
What Pharmacists Should Know About Biologics, Biosimilars
Understanding biosimilars will be crucial for pharmacists as interchangeability comes into play.
AbbVie Launches Multiple Myeloma Research Partnership
AbbVie and the International Myeloma Foundation will explore the outcomes of patients with multiple myeloma who have a specific genetic mutation.
Social Factors Could Impact HIV Mortality Risk
A history of incarceration and homelessness could indicate an increased mortality risk among patients with HIV.
Should Men Be Included in Breast Cancer Trials?
Breast cancer treatments may affect men differently than women.
Key Trends in Home Infusion, Specialty for 2018
Experts discuss expectations for home infusion and specialty pharmacy in 2018 at the MHA Business Summit.
Model Helps Predict Mortality Risk for Breast Cancer Survivors, Payers
Breast cancer survivors and insurance companies could gain a better understanding of mortality risk with a new model.
Curbing HIV/AIDS Epidemic Reliant on Social, Public Health Services
Social and public health providers linking patients to HIV services was found to increase retention in care.
Health Care Collaboration Could Slash Patient Mortality
Formal training may help health care teams work together more efficiently to improve outcomes.
Previous Chemotherapy Could Dampen Efficacy of CAR-T Cell Therapy
Fuel source of cancer cells could impact their efficacy of CAR-T cell therapies for pediatric patients.
Psychiatric Problems Could Predict Future Progressive Disability in MS Patients
Treating mental health disorders may reduce the risk of progressive multiple sclerosis.
Estrogen Inhibiting Drugs Show Promise in Muscular Dystrophy
Tamoxifen and raloxifene may improve muscle function among patients with muscular dystrophy.
Siponimod May Delay Disability Progression in Secondary Progressive Multiple Sclerosis
Treatment with siponimod reduced brain volume loss by 23% in patients with secondary progressive multiple sclerosis.
Link Confirmed Between Protein Mutation and ALS
Kinesin family member 5A mutations may cause amyotrophic lateral sclerosis.
Chlamydia Linked to Increased Ovarian Cancer Risk
Women with a prior chlamydia infection could have twice the risk of ovarian cancer.
FDA Approves Treatment for Moderate-to-Severe Plaque Psoriasis
The FDA has approved ILUMYA (tildrakizumab-asmn, Sun Pharma) for treating adults with moderate-to-severe plaque psoriasis.
Celebrating National Pharmacist Day
Show us how you and your pharmacy celebrate National Pharmacist Day by using #APharmacistIs on social media.
Plaque Psoriasis Drug Shows Strong Efficacy Versus Competitors
Risankizumab treats moderate to severe chronic plaque psoriasis.
Dairy Consumption Could Influence Breast Cancer Risk
New research indicates that high consumption of certain dairy products may either increase or decrease the risk of developing breast cancer, depending on the food.